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Objective: To describe and compare the epidemiological features of anthroponotic
cutaneous leishmaniasis (ACL) caused by Leishmania tropica, and zoonotic cutaneous
leishmaniasis (ZCL) due to Leishmania major in Morocco.
Methods: We performed a retrospective study of ZCL and ACL cases reported during
the last ten years in Morocco (2004–2013). Epidemiological data were analyzed by using
Pearson's correlation method as well as Tukey test and digital maps were produced for
incidence repartition calculated by using ArcMap GIS version 10.
Results: A total of 41656 cases of cutaneous leishmaniasis were notiﬁed between 2004
and 2013 in Morocco. The mean incidence was 139 cases/100000 population/10 years
and it was signiﬁcantly higher in 2010. In the spatial context, ACL form was the most
common in Morocco, while ZCL was the most important in terms of the number of
reported cases. For both forms, the highest incidence occurred in females and children (0–
14 years). When analyzed according to the number of cases in each province, Errachidia
(8728 cases) and Azilal (3523 cases) were the most affected by ZCL and ACL,
respectively, while the highest incidence was noted in Zagora (231 cases/100000 pop-
ulation/10 years) and in Chichaoua (97 cases/100000 population/10 years), for ZCL and
ACL, respectively. Maps of incidence repartition were performed to identify the risk area
of ZCL and ACL.
Conclusions: ZCL and ACL are still major health problems in Morocco. We highlight
the spatiotemporal change of cutaneous leishmaniasis incidence through the country
during the last ten years and we underline the correlation between ZCL incidence and the
percentage of rural population in Morocco.1. Introduction
Leishmaniases are parasitic diseases with a wide range of
clinical symptoms. In the skin, they range from localized cuta-
neous and mucocutaneous leishmaniasis to diffuse cutaneous
leishmaniasis (CL), whereas in the viscera they range from sub-
clinical to potentially fatal disease[1,2]. These parasitic protozoans
are usually transmitted to a human host via a bite by an infectedfemale phlebotomine sandﬂy (Diptera: Psychodidae) on exposed
parts of the human body. Leishmaniasis currently threaten 350
million persons in 88 countries[2].
Caused by three Leishmania species [Leishmania major (L.
major), Leishmania tropica (L. tropica) and Leishmania infan-
tum (L. infantum)], CLs are endemic, widespread and represent a
public health problem in most countries in the Mediterranean
basin[3].
In Morocco, CL is widely distributed as three nosogeographic
entities. L. major is transmitted by Phlebotomus papatasi and is
associatedwith zoonotic cutaneous leishmaniasis (ZCL) in the arid
regions along the northern edge of the Sahara desert[4–6].
L. infantum is transmitted by Phlebotomus ariasi and causes
zoonotic cutaneous disease (and mainly zoonotic visceral form)
in the north and centre-south regions of the country[5–7]. Lastly, L.
tropica, causative agent of anthroponotic cutaneous
leishmaniasis (ACL), is widespread in the semi-arid regions ofcess article under the CC BY-NC-ND license
Table 1
Geographic, demographic and epidemiologic characteristics of each
province affected by CL in Morocco.
CL
form
Provinces Latitude Longitude Rural
population
(%)
Incidence
(cases/100000
inhabitants/
10 years)
ZCL Boulemane* 33.363 −4.730 70.93 35.01
Errachidia* 31.934 −4.423 64.89 156.81
Figuig 32.213 −1.368 51.20 179.32
Jrada 34.312 −2.164 38.77 99.58
Midelt 32.684 −4.735 100.00 39.75
Ouarzazate* 30.907 −6.908 70.29 87.60
Taourirte 34.416 −2.900 42.29 0.10
Tata 29.746 −7.970 67.88 15.29
Tinghir 31.522 5.518 78.27 15.18
Zagora 30.332 −5.837 661.06 231.08
ACL Agadir
I Outanane
30.412 −9.604 21.10 0.23
Al haouz 31.307 −7.858 89.22 14.64
Al Hoceima 35.249 −3.938 70.06 2.65
Azilal 31.967 −6.569 83.81 69.83
Ben Slimane 33.616 −7.131 63.18 0.05
Be´ni Mellal 32.339 −6.355 52.71 5.99
Berkane 34.924 −2.320 42.24 0.22
Boulemane* 33.363 −4.730 70.93 11.61
Chefchaouen 35.171 −5.272 89.56 2.02
Chichaoua 31.545 −8.765 87.09 96.96
Chtouka
Ait Baha
30.071 −9.162 86.65 0.44
Driouach 34.982 −3.383 70.64 5.02
El jadida 33.241 −8.505 72.92 0.01
El kelaa
Sraghna
32.050 −7.409 75.95 1.07
Errachidia* 31.934 −4.423 64.89 0.45
Essaouira 31.514 −9.770 421.73 66.55
El Hajeb 33.693 −5.372 57.32 0.46
Fahs Anjra 35.766 −5.667 100.00 1.13
Fe`s 34.035 −5.000 2.33 0.84
Fkih Ben
salah
32.508 −6.694 100.00 6.31
Guelmim 34.234 −3.351 31.18 4.50
Guercif 34.233 −3.351 100.00 6.11
Inezgane
A Melloul
30.356 −9.550 8.10 0.17
Kenitra 34.263 −6.581 50.94 0.05
Khemisset 33.821 −6.069 58.03 0.19
Khenifra 32.939 −5.668 47.23 0.31
Larache 35.184 −6.151 53.52 1.40
Marrakech 31.637 −7.997 21.22 0.33
Meknes 33.893 −5.556 19.99 0.91
Mdiq
Fnideq
35.684 −5.330 6.40 0.58
Moulay
Yacoub
34.088 −5.181 97.90 5.32
Nador 35.168 −2.939 49.34 2.55
Ouazzane 34.800 −5.583 18.88 8.56
Ouarzazate* 30.907 −6.908 70.29 15.64
Sale 34.038 −6.803 6.56 1.03
Saﬁ 32.321 −9.219 52.86 0.05
Sefrou 33.831 −4.840 53.18 32.94
Settat 33.002 −7.621 66.16 6.11
Sidi Kacem 34.236 −5.713 69.91 17.88
Sidi Slimane 34.261 −5.923 100.00 37.66
Tanger
Assilah
35.777 −5.839 7.73 0.17
Taounate 35.249 −3.940 89.83 15.31
Taroudannte 30.468 −8.869 76.11 5.67
Taza 34.228 −4.021 66.33 12.96
Tetouan 35.577 −5.368 24.37 4.19
Tiznit 29.708 −9.730 75.97 0.26
*:Provinces with both ZCL and ACL forms.
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tomus sergenti (P. sergenti)[5,6,8]. Themain reservoirs for ZCL by L.
infantum and L.major, respectively, are dogs and rodents[9,10], with
humans fulﬁlling this function for ACL by L. tropica[11].
Over the past decade, the epidemiological situation of CL has
changed signiﬁcantly. It is acquiring an increasingly epidemic
status with geographic expansion to previously free areas and
the emergence of new foci in several provinces of Morocco. A
total of 24804 cases of L. major CL and 16852 cases of L.
tropica CL were recorded between 2004 and 2013 in Morocco.
L. infantum CL meanwhile is a rare condition with a few spo-
radic cases in the north of the country (especially in Sidi Kacem
Province) and few epidemiological data are available[5,12]. This
study was designed to describe and compare the
epidemiological features of L. major and L. tropica CL cases
during a ten year period (2004–2013) in Morocco.
2. Materials and methods
2.1. Study area and population
Located between the Atlantic and the Mediterranean between
latitudes 21N–36N and longitudes 1W–17W, Morocco was
placed in the extreme northwest of the African continent. It had
the most important permanent rivers in the Maghreb but suffers in
semi-arid to arid areas from a lack of water during all seasons[13].
Morocco's climate was Mediterranean and mainly characterized
by hot and dry summer where rainfall was almost completely
absent except in mountain areas (which have signiﬁcant
thunderstorm activity) and particularly high evaporation. It was
characterized also by a temperate to mild winter in the coastal
strip, cool to cold in the country's interior, on the chains of the
Atlas, in the Rif and the highlands of the eastern[14].
Morocco had a surface area of 710850 km2 and a population
of 29891708 with 13428074 inhabitants in rural areas[15].
2.2. Epidemiological data
The present study was a retrospective analysis of the CL in
Morocco. Epidemiological data were obtained from the bulle-
tins, registers and reports published by the local and national
medical services. These epidemiological data were recorded
after active or passive screening (leishmaniasis is a certiﬁable
disease in Morocco). We used clinical and epidemiological data
provided by the Moroccan Directorate of Epidemiology and
Fight Against Diseases, during 2004–2013[16].
2.3. GIS data base and statistic analysis
Digital mapswere produced for incidence repartition calculated
for the studied area by using ArcMap GIS version 10. The output
was two maps each depicting the incidence of ZCL and ACL.
All data were analyzed by using SPSS software and Pearson's
correlation method. Results were considered signiﬁcant when
the P-value was less than 0.05 by using a Tukey test.
3. Results
Table 1 shows the general characteristics of all provinces
(n = 52) affected by CL (ZCL and ACL) and the incidence (cases/
100000 inhabitants/10 years) of CL in Morocco. For ZCL, the
Kholoud Kahime et al./Journal of Acute Disease 2016; 5(1): 41–45 43highest incidence was observed in Zagora (231.08 cases/100000
inhabitants/study decade) and Figuig (179.32 cases/100000 in-
habitants/study decade), followed by Errachidia (156.81 cases/
100000 inhabitants/study decade). This high incidence could be
linked to the elevated percentage of rural populations in these
areas. The lowest incidence was determined in Taourirte (0.10
cases/100000 inhabitants/study decade) (Table 1).
Figure 1 presents the temporal evolution of CL (ZCL and
ACL) cases in Morocco between 2004 and 2013. The highest
CL cases were noted between 2008 and 2011 for ZCL and be-
tween 2010 and 2013 for ACL. The overall maximum of cases,
for both forms, was reported in 2010.Figure 1. Temporal evolution of CL (ZCL and ACL) cases in Morocco,
2004–2013.
Figure 3. Map showing geographical distribution of ACL incidence (cases d
between 2003 and 2014).Spatiotemporal analysis of ZCL (from 2004 to 2013) showed
a northward migration of the disease to Jrada and Taourirt
(Figure 2).Figure 2. Mapshowinggeographical distributionofZCL incidence (cases due
to L. major/100 000 population/(2003–2014 period) in Morocco provinces.
Ouarzazate: Ouarzazat + Thinghir.Concerning ACL, the highest incidence was observed in
Chichaoua (96.96 cases/100000 inhabitants/study decade)
followed by Azilal (69.83 cases/100000 inhabitants/study
decade), whereas the lowest incidence occurred in Kenitra,
Ben Slimane, Saﬁ, El Jadida with incidence between 0.05 and
0.01 cases/100000 inhabitants/study decade (Table 1,
Figure 3).ue to L. tropica/100 000 population/10 years) in Morocco (cases recorded
Kholoud Kahime et al./Journal of Acute Disease 2016; 5(1): 41–4544Epidemiological analysis of CL distribution according to age
and gender showed that all ages and both genders were affected
by the different forms of disease (Table 2). The analysis withTable 2
Epidemiological characteristics of CL in Morocco (2004–2013).
CL form Parameters Year Total P
2004 2005 2006 2007 2008 2009 2010 2011 2012 2013
ZCL Gender Male 619 998 971 598 1 458 1897 2 757 995 351 243 10 887 N.S
Female 722 1176 1193 754 1 973 2 505 3 687 1224 389 294 13 917
Total 1341 2174 2164 1352 3 431 4 402 6 444 2219 740 537 24 804
Age group < 5 years 202 273 334 210 523 816 1 038 414 214 188 4 212 P < 0.05
5–14 years 536 828 875 479 1392 1933 3 408 1156 322 134 11 063
15 years and above 603 1073 955 663 1516 1653 1998 649 204 215 9 529
Total 1341 2174 2164 1352 3431 4 402 6 444 2219 740 537 24 804
ACL Gender Male 406 381 506 816 729 699 1037 970 1009 929 7 482 N.S
Female 585 483 691 1122 968 912 1226 1130 1127 1 126 9 370
Total 991 864 1197 1938 1697 1611 2263 2100 2136 2 055 16 852
Age group < 5 years 232 214 359 470 610 584 896 858 864 926 6 013 P < 0.05
5–14 years 364 304 380 644 560 533 690 694 688 513 5 370
15 years and above 395 346 458 824 527 494 677 548 584 616 5 469
Total 991 864 1197 1938 1697 1611 2263 2100 2136 2 055 16 852
N.S: Not signiﬁcant.respect to age groups showed that children (less than 14 years)
were signiﬁcantly (P < 0.05) affected (62%; 67%) compared to
adults (38%; 33%) for ZCL and ACL, respectively (Table 2).
4. Discussion
Human CL is widely distributed in Morocco. Compared with
visceral leishmaniasis (3.17%), CL accounted for 96.83% of
leishmaniasis cases between 2004 and 2013. Within this CL form,
ZCL presented 57.63% (about 24804 cases), while ACL recorded
39.20% (16852 cases) of CL cases reported in the same period.
ZCL is the oldest leishmaniasis form in Morocco. In the pre-
Saharan area, it has been identiﬁed since 1914[17], in the palm
grove of Oued Tata, where a subsequent and major CL
epidemic was manifested during the late 1970s. After Tata,
two new epidemics were identiﬁed: one located along the
Draa, in the depression of Ouarzazate and the other on the
high plateau, south of Oujda[4,18]. Now identiﬁed as rampant in
the country, the disease has spread endemically both in the
per-arid Moroccan palm grove zone (the Tata-Akka-Foum
Z'Guid triangle in Ouarzazate Province and in the Northern
Oriental Highlands in the arid Ain-Beni Mathar strip[4,19].
Actually, ZCL in Morocco is caused by L. major zymodeme
MON-25 and transmitted by P. papatasi, with Meriones shawi
grandis as the main reservoir host[6].
About 73 years after ZCL's Moroccan identiﬁcation, the ACL
form was identiﬁed in 1987. Since 1997, it has been considered
as a major threat to public health[5]. It was widespread in semi-
arid regions, provinces in central and western slopes of the
Atlas Mountains, from Azilal in the centre up to Essaouira in the
west and Agadir-Guelmim in the south[8]. Currently, ACL is
transmitted by the sandﬂy P. sergenti, with human as the only
reservoir and caused by L. tropica with many zymodemes
(MON-102, MON-107, MON-109, MON-112, MON-113,
MON-122 and MON-123)[6].
Leishmaniasis affects both genders with an equal distribution
of cases between genders (56% female and 44% male for both
infections of ZCL and ACL). This may be related to the fact that
women sufferers seek medical advice more often than malecounterparts because of the unsightly lesions and the socio-
economic consequences for women of a perception of ‘unmar-
riageability’ due to unpleasing appearance[20].All ages are affected by the different forms of disease, with a
high incidence for young children who are at most risk. The
same result was recorded for L. tropica and L. major foci in
Morocco[21–23]. This marked correlation may be explained by the
inability of children's immune systems to ﬁght CL infection, as
well as the comparative resistance of older people to sandﬂy
bites[24]. The large numbers of women and children infected
also indicate that leishmania transmission may have occurred
in the peridomiciliary habitat[6].
According to urbanization, ACL (also known as the dry or
urban) is characterized by its strong rural and urban population,
in contrast to the high positive correlation between the ZCL
(also recognized as the wet or rural) incidence and percentage of
rural population (R2 > 0.49).
Moreover, over the past two decades, the epidemiological
situation of CL has changed signiﬁcantly. It acquired an
increasingly epidemic status with geographic expansion into
previously free areas in several provinces of South-east
Morocco[23]. According to Bounoua et al.[25], changes in
climate may have resulted in an increase in ZCL incidence in
Errachidia. In addition to noted global change, socio-economic
factors such as poverty, lack of infrastructure, lifestyle and
factors inﬂuencing the environment, appear to be among the
major underlying determinants of leishmaniasis in the region, a
result in agreement with previous studies[23,25,26].
Concerning ACL, the highest incidence was observed in Chi-
chaoua (96.96 cases/100000 inhabitants/study decade) and Azilal
(69.83 cases/100000 inhabitants/study decade). This propagation
may be related to the vector distribution. P. sergenti had an
extensive geographical distribution and it was also reported in all
bioclimatic rural as well as urban population habitats[6].
Furthermore, since humans constitute the only reservoir host for
ACL, the movement of populations (travel, migration, etc.) may
present a source of risk for the spread of the disease. These
hypotheses may explain the increase of the incidence of ACL
and its extension to new non-endemic areas in all directions.
This study reveals that ZCL and ACL pose a continuous and
important health problem in Morocco. In the light of our ﬁnd-
ings, the change of spatiotemporal CL incidence was identiﬁed.
Kholoud Kahime et al./Journal of Acute Disease 2016; 5(1): 41–45 45Epidemiological data clearly demonstrate the correlation be-
tween incidence of ZCL and the percentage of rural population
in different provinces. The cosmopolitan character of species
vector of ACL, and population movement may form a source of
risk for the spread of ACL disease. Additionally, theses diseases
may be linked to vector preferences, socio-economic conditions,
climate and environmental factors. Finally, the use of spatial
analyses is a highly useful tool in determining high incidence
risk zones.
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